(Courtesy: iStock)

Coronavirus

COVID-19 Bulletin (05/05/21)

The FDA is expected to approve Pfizer's vaccine for everyone 12 years of age and older.

Dallas County Judge Clay Jenkins reported 170 new COVID-19 cases and 5 deaths on Tuesday.


Doctors at Baylor University Medical Center are testing a new drug to combat against coronavirus variants. The treatment, a monoclonal antibody, neutralized all known variants of concern in preliminary lab tests with new trials that will test the new antibody’s efficacy in healthy adults recently diagnosed with COVID-19. Dallas Morning News has more. 


The FDA is expected to approve Pfizer’s COVID vaccine for ages 12 and older by next week, WFAA reported. President Biden said in a press conference that if approved the government will immediately move to make about 20,000 pharmacy sites across the country ready to vaccinate kids. 


Health experts in Texas are urging those who’ve received their first COVID-19 vaccine to not skip the second dose as more than 5% of Texans who had received the first dose were 43 days or more past due for their second dose. Increased vaccine hesitancy is causing a scare for Texas health officials as Texas’ vaccine surplus continues to grow. Read more here from the Texas Tribune.  

Newsletter

Keep me up to date on the latest happenings and all that D Magazine has to offer.

Comments